Clostridium Toxin and Method for Preparing Immunogenic Compositions

Details for Australian Patent Application No. 2007201975 (hide)

Owner Institut Pasteur

Inventors Gibert, Maryse; Popoff, Michel-Robert

Agent Cullen & Co

Pub. Number AU-B-2007201975

Parent 2002301780

Filing date 3 May 2007

Wipo publication date 24 May 2007

Acceptance publication date 3 September 2009

International Classifications

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

A61K 39/08 (2006.01) Medicinal preparations containing antigens or antibodies - Clostridium, e.g. Clostridium tetani

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Event Publications

17 May 2007 Complete Application Filed

24 May 2007 Application Open to Public Inspection

  Published as AU-B-2007201975

3 September 2009 Application Accepted

  Published as AU-B-2007201975

7 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007201976-Loci for Idiopathic Generalized Epilepsy, Mutations thereof and Method using same to Assess, Diagnose, Prognose or Treat Epilepsy

2007201974-Method and apparatus for determining a target amplification curve for a hearing device